26118 Federal Register / Vol. 73, No. 90 / Thursday, May 8, 2008 / Notices 

received no comments on this proposal. 

Therefore, the Bureau adopts its 

proposal. 

71. Finally, the Bureau notes that in 

the event of a default, the Commission 

may reauction the license or offer it to 

the next highest bidder (in descending 

order) at its final bid amount. In 

addition, if a default or disqualification 

involves gross misconduct, 

misrepresentation, or bad faith by an 

applicant, the Commission may declare 

the applicant and its principals 

ineligible to bid in future auctions, and 

may take any other action that it deems 

necessary, including institution of 

proceedings to revoke any existing 

licenses held by the applicant. 

F. Refund of Remaining Upfront 

Payment Balance 

72. All upfront payments submitted 

by applicants in Auction 77 may be 

available to be refunded after the 

conclusion of the auction; subject to any 

required payments (i.e. winning bid, 

deficiency, and/or default payments). 

All refunds will be returned to the payer 

of record, as identified on the FCC Form 

159, unless the payer submits written 

authorization instructing otherwise. 

Federal Communications Commission. 

Gary D. Michaels, 

Deputy Chief, Auctions Spectrum and Access 

Division, WTB. 

[FR Doc. E8–10381 Filed 5–7–08; 8:45 am] 

BILLING CODE 6712–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–08–0106] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–6974. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Preventive Health and Health Services 

Block Grant—Revision—National Center 

for Chronic Disease and Public Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Preventive Health and Health 

Services Block Grant program provides 

awardees with their primary source of 

flexible funding for health promotion 

and disease prevention programs. Sixtyone awardees (50 states, the District of 

Columbia, two American Indian Tribes, 

and eight U.S. territories) currently 

receive block grants from CDC in order 

to address locally defined public health 

needs in innovative ways. Block Grants 

allow awardees to prioritize the use of 

funds to fill funding gaps in programs 

that deal with leading causes of death 

and disability, as well as the ability to 

respond rapidly to emerging health 

issues. 

CDC currently collects standardized 

application and performance 

information from each awardee through 

an electronic Grant Application and 

Reporting System (GARS). In response 

to measures described in the 

Government Performance Results Act, 

CDC proposes to replace GARS with a 

web-based Block Grant Management 

Information System (BG-MIS) that will 

collect information by the areas 

described in Healthy People 2010 and 

improve adherence to its goals. 

Concurrent with conversion to the BGMIS, minor changes to the questions 

and response options, and other 

features, will be implemented to reduce 

respondent burden and support the 

Healthy People 2010 framework. These 

features include increased utilization of 

pre-defined response options, start and 

end dates, the SMART (Specific, 

Measurable, Achievable, Realistic, and 

Time-based) format for describing 

objectives, and identification of 

Evidence Based Guidelines and Best 

Practices used as the basis for public 

health programs and interventions. In 

addition, a Compliance Review section 

has been added to provide each awardee 

with general information regarding the 

Compliance Review process and 

specific information pertaining to its 

past reviews. 

Information will be collected twice 

per year. Each awardee will submit an 

annual Work Plan outlining awardeespecific health outcome objectives and 

an Annual Report describing progress 

toward its goals. 

There are no costs to respondents 

except their time. The estimated 

annualized burden hours are 3,355. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

PHHS Block Grant Awardees ......................... Work Plan ....................................................... 61 1 25 

Annual Report ................................................ 61 1 30 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 73, No. 90 / Thursday, May 8, 2008 / Notices 26119 

Dated: April 30, 2008. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E8–10215 Filed 5–7–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0063] (formerly 

Docket No. 2008N–0016) 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Exports: 

Notification and Recordkeeping 

Requirements 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by June 9, 

2008. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–6974, or e-mailed to 

baguilar@omb.eop.gov. All comments 

should be identified with the OMB 

control number 0910–0482. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Jonna Capezzuto, Office of the Chief 

Information Officer (HFA–250), Food 

and Drug Administration, 5600 Fishers 

Lane, Rockville, MD 20857, 301–827–

4659. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Exports: Notification and 

Recordkeeping Requirements—(OMB 

Control Number 0910–0482)—Extension 

The respondents to this information 

collection are exporters who have 

notified FDA of their intent to export 

unapproved products that may not be 

sold or marketed in the United States as 

allowed under section 801(e) of the 

Federal Food, Drug, and Cosmetic Act 

(the act) (21 U.S.C. 381(e)). In general, 

the notification identifies the product 

being exported (e.g. name, description, 

and in some cases, country of 

destination) and specifies where the 

notification should be sent. These 

notifications are sent only for an initial 

export; subsequent exports of the same 

product to the same destination (or, in 

the case of certain countries identified 

in section 802(b) of the act (21 U.S.C. 

382(b)), to any of those countries would 

not result in a notification to FDA. 

The recordkeepers to this information 

collection are exporters who export 

human drugs, biologics, devices, animal 

drugs, foods and cosmetics that may not 

be sold in the United States to maintain 

records demonstrating their compliance 

with the requirements in section 

801(e)(1) of the act. 

The total burden estimate of 39,120 is 

based on the number of notifications 

received by the relevant FDA centers in 

fiscal year 2007, or the last year the 

figures were available. 

In the Federal Register of January 28, 

2008 (73 FR 4874), FDA published a 60- 

day notice requesting public comment 

on the information collection 

provisions. No comments were received. 

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

21 CFR Section No. of 

Respondents 

Annual Frequency 

per Response 

Total Annual 

Responses 

Hours per 

Response Total Hours 

1.101(d) and (e) 400 3 1,200 15 18,000 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1

21 CFR Section No. of 

Recordkeepers 

Annual Frequency 

per 

Recordkeeping 

Total Annual 

Records 

Hours per 

Record Total Hours 

1.101(b) and (c) 320 3 960 22 21,120 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Dated: May 1, 2008. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E8–10204 Filed 5–7–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Anti-Infective Drugs Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Anti-Infective 

Drugs Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on July 16, 2008, from 8 a.m. to 5 

p.m. 

Location: Food and Drug 

Administration, Center for Drug 

Evaluation and Research Advisory 

mstockstill on PROD1PC66 with NOTICES